The ONE Project was an oncology nurses' education project conducted in May 2014 in Bahrain. It aimed to provide educational programs targeting oncology nurses to improve their disease awareness, adverse event management skills, and ability to improve patient outcomes. Over 30 nurses attended educational sessions on various cancer types and management of adverse events from Roche's oncology portfolio. The project received positive feedback and was accredited by the Ministry of Health. It established Roche as committed to raising disease awareness and opened opportunities for future patient access programs.

1. The ONE Project
Oncology Nurses’ Education Project
Wave I
May 2014

2. Doing now what patients need next
What to do ?
How to do ?
Who to target ?

3. HCPs’ Segments in Bahrain
GI
Specialists
Gynecologists
Surgeons
Patients
Oncology
Nurses
N=103
Medical
Oncologists
N= 3
Radiation
Oncologists
N=7
Senior
Hematologists
N=4
Resident
Medical
Oncologists
N=5
Hematologists
N=2
Pathologists
Others

4. • Nursing knowledge may support clinical decision
making
• Nursing interactions and interventions may
influence a significant change in health status
Integral role in
healthcare system ,
Cancer care delivery
and clinical Practice
• Pharma companies focus on medical
sponsorships of specialists and TAEs
• No Educational programs targeting oncology
nurses and address their potential challenges .
Nurses are the least
HCPs’ segment benefit
from educational
medical sponsorships
• Nurses interact physically , emotionally , socially
and spiritually with patients and their families
• Oncology Nurses’ disease and proper side
effects management improve patient
engagement to treatment , promote patient
safety and empower patients to beat cancer.
Oncology Nurses’
knowledge correlated
with patient outcomes
improvement
The ONE Mission :
Targets Oncology Nurses

5. The ONE Mission :
Why Nurses 'education is crucial?
Oncology
Nurses
Education
Deliver Quality disease awareness
to patients through synergy of
Physical , intellectual , emotional
And spiritual skills and knowledge
Promote patient safety and
quality cancer cancer through
Proper adverse events
management
Improve patient treatment outcomes by reducing the patient’s Treatment /cycle
interruption , suspension . Discontinuation And allow optimal treatment duration
Oncology Nursing education
May affect cost-effectiveness
Strategies (e.g. Reducing time of
Hospitalization )
Contribute to patients’ clinical
Decisions and incorporate nurses
Into landmark medical projects .

6.  Short term :
• Adopt comprehensive educational program to oncology nurses to empower their
awareness in various tumor types .
• Educate nurses on reliable means to manage adverse events of Roche oncology
portfolio
• Establish strong nursing models with high capabilities to prevent avoidable
complications of Roche oncology portfolio.
 Mid-Long Term:
• Promote quality nursing to improve patient safety and optimize cancer care delivery .
• Incorporate Nurses into the entire clinical practice through continues formalized
specialized nursing education programs .
• Enhance patients 'optimal treatment duration by Minimizing treatment events
discontinuation ,suspension or interruption due to adverse events improper
management
• Correlate cost effective strategies with hospitalization cost burden due to improper
management of adverse events and the urgent need to encourage nurses training .
The ONE Mission :
Objectives

7. • MOH perception towards the ONE and Roche role in education HCPs.
• Number of oncology nurses attending the ONE sessions.
• The ONE effectiveness measurement tool (The One Evaluation Sheet ) to
grade following :
 Scientific Content of sessions .
 Speakers Quality ,
 Reliability of the ONE with oncology nurses’ daily practice .
 The ONE Guidance to manage adverse events and prevent avoidable
complications
 Interest to run THE ONE wave II..
The ONE Mission :
KPIs

8. The ONE Mission
Evaluation Sheet .“The One” Post Evaluation Sheet
Name : Position:
Email: Tel:
Speakers Rating
Dr Jaffer Tooq 1 2 3 4 5
Dr Hussain Ismaeel 1 2 3 4 5
Mr Khaled Ghozlan 1 2 3 4 5
Mr Emad Said 1 2 3 4 5
Mrs. Zein Gharibah 1 2 3 4 5
Scientific Contents
1. BC disease background 1 2 3 4 5
2. OC disease background 1 2 3 4 5
3. LC disease background 1 2 3 4 5
4. CRC disease background 1 2 3 4 5
5. Lymphoma Disease background 1 2 3 4 5
6. Glioblastoma Disease background 1 2 3 4 5
7. Trastuzumab Adverse events management 1 2 3 4 5
8. Bevacizumab Adverse events management 1 2 3 4 5
9. Erlotinib Adverse events management 1 2 3 4 5
10. Capecitabine Adverse events management 1 2 3 4 5
11. Rituximab Adverse events management 1 2 3 4 5
About the ONE Program
Topics Rating
Does the ONE upgrade your knowledge in
various cancer types? 1 2 3 4 5
How the adverse events management guidance
allows you control avoidable complications? 1 2 3 4 5
How do you recommend the ONE program for
your colleagues who didn’t attend wave I ? 1 2 3 4 5
To what extent , the ONE program content could
affect your interaction with cancer patients ? 1 2 3 4 5

9. • MOH adopted the ONE as the reference template for any future oncology
nurses’ educational program .
• The ONE is the first nurses’ educational program accredited by MOH as CME
points
• Number of attendees exceeded 30 nurses in average per session .
• The ONE evaluation sheet showed high interest to recommend the ONE wave II
with positive feedback regarding the event organization , speakers , content and
correlation with nurses daily challenges .
• Roche team was highly appreciated by Oncology training committee for the
Roche dedication and commitment to raise disease awareness and enhance
knowledge retention .
• Roche team received appreciation certificates acknowledging their high level
cooperation towards HCPs and national society.
• The ONE opened new opportunities for patient access in different Roche
assigned disease areas (RA and Virology ) through building an innovative access
with MOH key stakeholders concerned with patient supporting programs .
The ONE Mission :
Results

10. • New Partnership Model established with HCPs to deepen cancer knowledge ,
understand human diseases and provide means for prevention , detection ,
monitoring and treatment .
• Roche patient access , The ONE program engaged new stakeholders who are
concerned with running effective patient supporting programs in different
therapeutic areas.
• Management of Roche Oncology Portfolio Adverse Events , to promote patient
safety , improve patients’ treatment outcomes by maintaining optimal treatment
duration without interruptions or suspension
• Exploring new HCPs’ segment (Oncology Nurses ‘ Education) by analyzing
medical needs and share with HCPs their thoughts , challenges and potential
problems they face on daily practice . The ONE delivered comprehensive
formalized information specific to nurses and related to their daily problems .
• Effectiveness measurement tool of the ONE , provide full feedback about the
activity , assess gaps , points of improvement and transfer them to better
opportunities .
The ONE Mission :
Results _Roche Perspectives

11. • Corporate Responsibility and Team Spirit , Roche team is committed to
satisfy legitimate information interests in transparent , fair and accurate way . The ONE
showed cross-functional interactions (Regulatory , Communication ), engaging
oncology commercial tem to share their input in fulfilling Roche high corporate
responsibility and expectations in a smooth , non-branded and educational intention.
• Peer-to-Peer Interaction with HCPs,, Sharing our thoughts and expectations
with HCPs inspired them to be a part of the project , sharing presentations of the disease
background, facilitate communication between different MOH sectors , provide
approvals for CME points that led to MOH adoption of oncology nurses’ education
coming programs under the title (The ONE)
The ONE Mission :
Results _Roche Perspectives

12. The ONE Mission :
Why the ONE ??
Roche Assigned indications and Oncology Portfolio
briefed in ONE Program
The ONE
Oncology Nurses’
Education Project
BC Disease
Background
OC Disease
Background
LC Disease
Background
CRC Disease
Background
GBM Disease
Background
Xeloda AE
Management
Tarceva AE
Management
Avastin AE
Management
Herceptin AE
Management

13. The ONE Mission :
Why the ONE ??
ONE Roche Team
• Th0e ONE is an example of orchestrating medical and commercial activities and aligning
with Roche priority objectives in 2014
• Despite the ONE is independent to commercial influence , it succeeded to position
commercial team input to be purely educative and non-promotional
• The ONE engage cross-functional teams and high management to participate in process ,
advice , input and shared

14. ONE Peer-to-Peer legitimate Relationship
• Peer-To-Peer Interactions with HCPs with high level of dedication , commitment
and expectations contributed to the program excellent perception by MOH
stakeholders .
• Oncology Training Committee and Roche team formulate ONE team to initiate
project communication , preparation and implementation
• Delivery of quality non-promotional , educational and scientific programs to
HCPs in alignment with Roche strategies and the symphony implementation
plan .
• The ONE will give rise to new patient access programs opportunities in other
Roche assigned disease areas (RA and Hepatitis ) as a result of enhanced access
with stakeholders concerned about patient supporting programs .
The ONE Mission :
Why the ONE ??

15. • Disease Background Patient Awareness Flyers
• CME Accreditation of the program by MOH
• Adverse events management booklets
• Xeloda HFS management patient kits .
• BC Survivor Awareness Video .
• The ONE Wave II (NOV-DEC 2014)
The ONE Mission
What is beyond The ONE ?

16. The ONE Mission
Back-up slides

17. The ONE Mission
Back-up slides

18. The ONE Mission
Back-up slides

19. The ONE Mission
Back-up slides

20. The ONE Mission

21. The ONE Mission